Hematopoietic stem cell gene therapy with drug resistance genes: an update.
about
Molecularly evolved thymidylate synthase inhibits 5-fluorodeoxyuridine toxicity in human hematopoietic cellsNeoceptors: reengineering GPCRs to recognize tailored ligandsInterfering RNA-mediated purine analog resistance for in vitro and in vivo cell selection.Gene-modified bone marrow cell therapy for prostate cancer.Development of gene therapy in association with clinically used cytotoxic deoxynucleoside analogues.
P2860
Hematopoietic stem cell gene therapy with drug resistance genes: an update.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Hematopoietic stem cell gene therapy with drug resistance genes: an update.
@ast
Hematopoietic stem cell gene therapy with drug resistance genes: an update.
@en
type
label
Hematopoietic stem cell gene therapy with drug resistance genes: an update.
@ast
Hematopoietic stem cell gene therapy with drug resistance genes: an update.
@en
prefLabel
Hematopoietic stem cell gene therapy with drug resistance genes: an update.
@ast
Hematopoietic stem cell gene therapy with drug resistance genes: an update.
@en
P2093
P2860
P356
P1433
P1476
Hematopoietic stem cell gene therapy with drug resistance genes: an update.
@en
P2093
Debabrata Banerjee
Joseph R Bertino
Tulin Budak-Alpdogan
P2860
P2888
P304
P356
10.1038/SJ.CGT.7700866
P577
2005-11-01T00:00:00Z